Open Access

Ell3 stimulates 5-FU resistance in a breast cancer cell line

  • Authors:
    • Isaac Kim
    • Kwang‑Soo Kim
    • Ok‑Seon Kwon
    • Hyuk‑Jin Cha
    • Kyung‑Soon Park
  • View Affiliations

  • Published online on: April 5, 2017     https://doi.org/10.3892/ol.2017.5996
  • Pages: 4173-4179
  • Copyright: © Kim et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Ell3 is an RNA polymerase II transcription elongation factor that acts as a negative regulator of p53 expression, and regulates cell proliferation and survival. Recent studies by our group have demonstrated that ectopic expression of Ell3 in breast cancer cell lines enhances cell proliferation, potentiates cancer stem cell properties, and promotes 5-Fluorouracil (5‑FU) resistance. In the present study, the underlying mechanism for the induction of 5‑FU resistance was investigated in Ell3 over‑expressing MCF‑7 cells (Ell3 OE cells). By comparing the gene expression profiles of Ell3 OE cells with control cells, the present data revealed that Lipocalin2 (LCN2) and Wnt signaling activity are associated with 5-FU resistance of Ell3 OE. siRNA‑mediated suppression of LCN2 reversed 5‑FU resistance in Ell3 OE cells. Chemical inhibition of Wnt signaling also reversed 5‑FU resistance in Ell3 OE cells. Furthermore, the expression levels of survivin, which is a direct transcriptional target of Wnt/β‑catenin and an inhibitor of apoptosis, were markedly elevated when Ell3 OE cells were treated with 5‑FU, as detected by western blot analysis. These findings suggest that enhanced expression of LCN2 and activation of the Wnt signaling pathway may induce 5‑FU resistance in Ell3 OE cells as a means of evading apoptosis.
View Figures
View References

Related Articles

Journal Cover

June-2017
Volume 13 Issue 6

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Kim I, Kim KS, Kwon OS, Cha HJ and Park KS: Ell3 stimulates 5-FU resistance in a breast cancer cell line. Oncol Lett 13: 4173-4179, 2017.
APA
Kim, I., Kim, K., Kwon, O., Cha, H., & Park, K. (2017). Ell3 stimulates 5-FU resistance in a breast cancer cell line. Oncology Letters, 13, 4173-4179. https://doi.org/10.3892/ol.2017.5996
MLA
Kim, I., Kim, K., Kwon, O., Cha, H., Park, K."Ell3 stimulates 5-FU resistance in a breast cancer cell line". Oncology Letters 13.6 (2017): 4173-4179.
Chicago
Kim, I., Kim, K., Kwon, O., Cha, H., Park, K."Ell3 stimulates 5-FU resistance in a breast cancer cell line". Oncology Letters 13, no. 6 (2017): 4173-4179. https://doi.org/10.3892/ol.2017.5996